Not applicableStudy completedNCT05147571What this trial is testingRNS System NAUTILUS StudyWho this might be right forEpilepsyIdiopathic Generalized EpilepsyGeneralized Tonic Clonic Seizure NeuroPace 100
Not applicableLooking for participantsNCT06657378What this trial is testingEvaluate the Safety of Fycompa Injection in Participants With Partial-Onset Seizures or Primary Generalized Tonic- Clonic SeizuresWho this might be right forPartial-Onset SeizuresPrimary Generalized Tonic-clonic Seizures Eisai Co., Ltd. 110
Large-scale testing (Phase 3)Study completedNCT01393743What this trial is testingA Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic SeizuresWho this might be right forSeizure Disorder Generalized Tonic Clonic Eisai Inc. 163
Large-scale testing (Phase 3)Enrolling By InvitationNCT07287163What this trial is testingClinical Trial of Vormatrigine in Adult Patients With EpilepsyWho this might be right forEpilepsy, Tonic-ClonicFocal SeizurePrimary Generalized Seizure Praxis Precision Medicines 700
Large-scale testing (Phase 3)Ended earlyNCT00692003What this trial is testingAdjunctive Zonisamide in Primary Generalised Tonic Clonic SeizuresWho this might be right forEpilepsy Eisai Limited 21
Testing effectiveness (Phase 2)Study completedNCT00210652What this trial is testingAn Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With EpilepsyWho this might be right forEpilepsyEpilepsies, Partial SK Life Science, Inc. 47
Large-scale testing (Phase 3)Study completedNCT02408549What this trial is testingSafety and Efficacy of Lacosamide as Additional Therapy in Patients Suffering From Epileptic Tonic-Clonic SeizuresWho this might be right forEpilepsy UCB BIOSCIENCES, Inc. 239
Post-approval studies (Phase 4)Study completedNCT00043901What this trial is testingTreatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New DrugWho this might be right forEpilepsy, Tonic-Clonic GlaxoSmithKline 141
Large-scale testing (Phase 3)Looking for participantsNCT06579573What this trial is testingONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.Who this might be right forEpilepsy, Generalized Ono Pharmaceutical Co., Ltd. 15
Large-scale testing (Phase 3)Study completedNCT00236704What this trial is testingThe Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic SeizuresWho this might be right forEpilepsySeizures Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Testing effectiveness (Phase 2)Looking for participantsNCT07130786What this trial is testingProphylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain MetastasesWho this might be right forSeizuresPrimary Motor CortexBrain Metastases From Non-small Cell Lung Cancer (NSCLC)+2 more Ayal A. Aizer, MD 150
Testing effectiveness (Phase 2)Looking for participantsNCT06908356What this trial is testingAn Open Label Trial to Evaluate the Efficacy and Safety of PRAX-628 in Adults With Focal Onset or Tonic-Clonic SeizuresWho this might be right forFocal Onset SeizurePrimary Generalized Epilepsy Praxis Precision Medicines 50
Large-scale testing (Phase 3)Study completedNCT00160550What this trial is testingStudy to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic SeizuresWho this might be right forGeneralized Convulsive Epilepsy UCB Pharma 154
Large-scale testing (Phase 3)Study completedNCT01463306What this trial is testingA 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic SeizuresWho this might be right forEpilepsy, Partial SeizuresEpilepsy, Primary Generalized Tonic-Clonic Seizures Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 605
Not applicableStudy completedNCT04202159What this trial is testingEvaluate the Effectiveness of Perampanel as Only Add-on Treatment in Participants With Primary or Secondarily Generalized Tonic-clonic SeizuresWho this might be right forSeizures Eisai GmbH 187
Not applicableNo Longer AvailableNCT02307578What this trial is testingAn Extended Access Program (EAP) for PerampanelWho this might be right forPrimary Generalized Tonic-Clonic or Partial Onset SeizuresLennox Gastaut Syndrome Eisai Inc.
Testing effectiveness (Phase 2)Study completedNCT03754582What this trial is testingIntravenous Perampanel in Japanese Participants With EpilepsyWho this might be right forEpilepsySeizures Eisai Co., Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT01118949What this trial is testingOpen-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With EpilepsyWho this might be right forEpilepsy UCB BIOSCIENCES, Inc. 49
Large-scale testing (Phase 3)Study completedNCT01747915What this trial is testingA Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.Who this might be right forGeneralized Tonic Clonic Seizures Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 219
Large-scale testing (Phase 3)Looking for participantsNCT05667142What this trial is testingEvaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresWho this might be right forPrimary Generalized Tonic-Clonic Seizures Xenon Pharmaceuticals Inc. 160